Company Nuo Therapeutics Inc OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 19 | Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 19 | Exor-backed NUO invests in Italian teenage clothing chain Subdued | RE |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Cell-based Technologies
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +442.12% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +442.12% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Jorden
CEO | Chief Executive Officer | 61 | 08-09-18 |
Peter Clausen
COO | Chief Operating Officer | 58 | 08-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
C. Eric Winzer
BRD | Director/Board Member | 67 | 09-01-29 |
David Jorden
CEO | Chief Executive Officer | 61 | 08-09-18 |
Paul D. Mintz
BRD | Director/Board Member | 75 | 17-04-06 |
Scott Pittman
BRD | Director/Board Member | 65 | 16-05-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 44,241,516 | 17,391,995 ( 39.31 %) | 0 | 39.31 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.87% | 22.15B | |
-17.37% | 21.02B | |
-8.10% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- AURX Stock
- Stock
- Company Nuo Therapeutics Inc